What the exam tests in haematology and oncology
Haematology questions start with a blood result. You will see a full blood count, iron studies, a blood film comment or a coagulation profile and must decide what it means and what to do next. The skill being tested is pattern recognition plus a safe next step. A microcytic anaemia in an older man is not just iron deficiency; it is a reason to look for a bowel cancer. A low platelet count after heparin is not just a number; it is a reason to stop heparin and change anticoagulant.
Oncology questions are set mostly in general practice and the emergency department. The AMC wants a doctor who can screen the right people, refer suspected cancer on the right pathway, recognise emergencies in patients on treatment, and support patients at the end of life. You are not expected to choose chemotherapy regimens. You are expected to know that a febrile patient on chemotherapy needs antibiotics within an hour.
Many stems combine the two: a myeloma presentation with back pain and high calcium, a lymphoma with night sweats and a mediastinal mass, an acute leukaemia found on a routine blood test. Read for the systemic clues (weight loss, fevers, bone pain, bruising, recurrent infection) that turn a simple abnormality into a serious diagnosis.
- Interpretation: MCV, ferritin, transferrin saturation, reticulocytes, film findings, INR and APTT
- Next step: which test confirms the cause, and which patients need urgent referral
- Emergencies: neutropenic sepsis, spinal cord compression, hypercalcaemia, tumour lysis, SVC obstruction
- Population health: screening program ages and intervals, and who should not be screened
High-yield topics part 1: anaemia and iron disorders
Sort anaemia by MCV. Microcytic anaemia is usually iron deficiency or thalassaemia trait. A low ferritin confirms iron deficiency, but ferritin rises with inflammation, so a normal ferritin in an unwell patient does not exclude it; transferrin saturation helps. In thalassaemia trait the red cell count is often normal or high and ferritin is normal. Haemoglobin electrophoresis (or high performance liquid chromatography) confirms beta thalassaemia trait; alpha thalassaemia trait often needs DNA testing. Partner testing before or early in pregnancy matters in people from Mediterranean, Middle Eastern, South Asian, Southeast Asian and African backgrounds.
Iron deficiency in a man or a postmenopausal woman needs a cause. Ask about diet, blood loss, NSAIDs and coeliac symptoms, test coeliac serology, and refer for gastroscopy and colonoscopy. In premenopausal women heavy menstrual bleeding is common, but upper and lower gut symptoms, family history or failure to respond still need investigation. Oral iron is first line; intravenous iron is used when oral iron fails or is not tolerated, or when a faster response is needed, such as late pregnancy or before surgery.
Macrocytic anaemia points to B12 or folate deficiency, alcohol, liver disease, hypothyroidism, medicines (methotrexate, hydroxyurea) or myelodysplasia. B12 deficiency can cause neurological damage, including subacute combined degeneration of the cord. If both B12 and folate are low, replace B12 first or together, because folate alone can worsen neurological disease. Causes include pernicious anaemia, a strict vegan diet, metformin, and gastric or ileal surgery.
Haemolysis shows anaemia with high reticulocytes, high bilirubin (unconjugated), high LDH and low haptoglobin. The direct antiglobulin test separates immune from non-immune causes. Think of G6PD deficiency after oxidant drugs or fava beans, hereditary spherocytosis with a family history, and microangiopathic haemolysis (schistocytes plus low platelets) in TTP or haemolytic uraemic syndrome, which are emergencies.
- Hereditary haemochromatosis: high transferrin saturation and ferritin; check HFE genotype; C282Y homozygosity is the classic result; treat with venesection, and screen first-degree relatives
- In Australia, people with haemochromatosis may be able to donate blood for therapeutic venesection through Australian Red Cross Lifeblood
- Anaemia of chronic disease: normocytic or mildly microcytic, ferritin normal or high, low transferrin saturation
- Sickle cell crisis: oxygen, fluids, analgesia, look for infection and acute chest syndrome
High-yield topics part 2: platelets, bleeding and venous thromboembolism
Low platelets need a careful history. Immune thrombocytopenia is a diagnosis of exclusion with isolated low platelets and a normal film. Always ask about medicines, alcohol, recent viral illness, pregnancy and heparin. Heparin-induced thrombocytopenia typically appears five to ten days after starting heparin, with a fall in platelets and sometimes new clots. Stop all heparin and start a non-heparin anticoagulant. Do not give platelets unless advised by a haematologist.
Coagulation patterns are high yield. A prolonged APTT alone suggests haemophilia A or B, von Willebrand disease, heparin or a lupus anticoagulant. A prolonged INR alone suggests warfarin, liver disease or vitamin K deficiency. Both prolonged with low platelets and low fibrinogen suggests disseminated intravascular coagulation. Von Willebrand disease is the most common inherited bleeding disorder and often presents as heavy periods or bleeding after dental work.
For suspected deep vein thrombosis or pulmonary embolism, use pre-test probability first (for example the Wells score). In low probability, a normal D-dimer can exclude VTE. In high probability, go straight to imaging. Direct oral anticoagulants (apixaban, rivaroxaban, dabigatran) are first line for most patients. Warfarin is preferred in mechanical heart valves and in high-risk antiphospholipid syndrome, and DOACs are avoided in pregnancy, where low molecular weight heparin is used. Provoked VTE usually needs about three months of treatment; unprovoked VTE often needs longer, guided by bleeding risk.
Warfarin reversal is a frequent stem. A high INR without bleeding is managed by withholding doses, with vitamin K if the INR is very high. Major bleeding needs vitamin K intravenously plus prothrombinex (prothrombin complex concentrate) and fresh frozen plasma if needed, following Australian consensus guidance. DOAC reversal uses specific agents where available, such as idarucizumab for dabigatran.
- Thrombophilia testing is not routine after a provoked VTE and should not be done in the acute phase or on anticoagulants
- Cancer-associated VTE: DOAC or LMWH depending on bleeding risk and cancer type
- Transfusion reactions: stop the transfusion first, keep the line open with saline, check the patient and the bag identity
- ABO incompatibility is a clinical emergency and usually reflects an identification error
High-yield topics part 3: leukaemia, lymphoma, myeloma and oncological emergencies
Acute leukaemia presents with marrow failure: anaemia, infection and bleeding, often with blasts on the film. The next step is urgent same-day haematology referral. Acute promyelocytic leukaemia is linked to DIC and is a medical emergency. Chronic lymphocytic leukaemia is often found on a routine blood test as a high lymphocyte count in an older adult with smear cells; many patients are watched without treatment. Chronic myeloid leukaemia gives a very high white cell count with a left shift and splenomegaly, and the Philadelphia chromosome (BCR-ABL) guides tyrosine kinase inhibitor treatment.
Lymphoma presents with painless lymph nodes, sometimes with fever, night sweats and weight loss. The test that makes the diagnosis is an excision or core biopsy of a node, not fine needle aspiration alone. Myeloma is the classic older patient with bone pain, anaemia, high calcium and renal impairment. Serum protein electrophoresis with immunofixation and serum free light chains are the key tests.
Neutropenic sepsis is the emergency the exam tests most. Any patient who has had chemotherapy recently and has a fever, or feels unwell even without fever, should be treated as neutropenic sepsis until shown otherwise. Give empirical broad-spectrum intravenous antibiotics within one hour, as set out in Therapeutic Guidelines and eviQ. Do not wait for the neutrophil count. Other emergencies: tumour lysis syndrome (high potassium, phosphate and urate, low calcium) after treatment of bulky or fast-growing cancers; hypercalcaemia of malignancy treated with IV fluids then a bisphosphonate; SVC obstruction with facial swelling and distended neck veins.
- Myeloproliferative disorders: polycythaemia vera (JAK2, venesection, aspirin), essential thrombocythaemia, myelofibrosis
- Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9) support monitoring and some diagnoses but are not screening tests for the general population
- PSA in Australia: informed shared decision with men about testing; no organised population program
- Palliative care: regular analgesia by the clock, treat breakthrough pain, anticipate nausea and constipation with opioids, plan with the patient and family
Australian practice: national screening programs and referral pathways
Australia runs organised population screening programs, and the AMC tests their details. Many candidates lose marks by applying UK or home-country ages and intervals. Know who is eligible, the test, how often, and what to do with a positive result.
The National Bowel Cancer Screening Program offers a free immunochemical faecal occult blood test (iFOBT) every two years to people aged 45 to 74. A positive result needs colonoscopy, not a repeat stool test. People with symptoms such as rectal bleeding or iron deficiency should not be screened; they need diagnostic investigation. BreastScreen Australia invites women aged 50 to 74 for a mammogram every two years, and women aged 40 and over can attend. The National Cervical Screening Program uses an HPV test every five years for women and people with a cervix aged 25 to 74, and self-collection is an option for everyone eligible.
The National Lung Cancer Screening Program, which began in July 2025, offers a low-dose CT scan every two years to people aged 50 to 70 without symptoms who have a significant smoking history and either still smoke or quit within the past ten years. There is no national program for prostate cancer; PSA testing is an informed choice after discussion. Australia has no organised skin cancer screening program, but opportunistic skin checks for high-risk people are common in general practice.
Australia uses Optimal Care Pathways from Cancer Australia and Cancer Council to guide referral timelines for suspected cancer. eviQ, run by the Cancer Institute NSW, is the national resource for cancer treatment protocols and many emergency management guides. Aboriginal and Torres Strait Islander people have higher cancer death rates for several cancers, and culturally safe care and access to screening are expected in exam answers.
- Bowel: iFOBT every 2 years, ages 45 to 74; positive means colonoscopy
- Breast: mammogram every 2 years, invited ages 50 to 74
- Cervical: HPV test every 5 years, ages 25 to 74; self-collection available
- Lung: low-dose CT every 2 years for eligible people aged 50 to 70 with a heavy smoking history
- Symptomatic patients are investigated, not screened
How to approach haematology and oncology stems
First, decide if the patient is unwell. A febrile patient on chemotherapy, a bleeding patient on warfarin, or a patient with very low platelets and confusion needs treatment before any further testing. Second, look at the pattern. Is one cell line abnormal or several? Several abnormal lines suggest marrow failure, infiltration or hypersplenism. Third, ask what explains the pattern in this person: age, sex, ethnicity, medicines, diet and symptoms.
When the lead-in asks for the most appropriate investigation, choose the test that confirms the cause, not just one that adds another number. Iron deficiency in an older adult leads to endoscopy. A paraprotein leads to free light chains and marrow assessment. A lymph node leads to biopsy. When the lead-in asks for next step in screening, check whether the patient is in the screening age band and is truly asymptomatic. Symptoms move the patient from screening to diagnosis.
- Pancytopenia plus blasts: same-day haematology referral
- Fever plus recent chemotherapy: antibiotics within 60 minutes, then cultures and counts in parallel
- Bone pain plus high calcium plus renal impairment: think myeloma
- Positive screening test: diagnostic test next, never a repeat screen
| Pattern | Common causes | Next step the exam expects |
|---|---|---|
| Microcytic, low ferritin | Iron deficiency from blood loss or malabsorption | Find the cause: coeliac serology, endoscopy and colonoscopy in men and postmenopausal women |
| Microcytic, normal ferritin, high red cell count | Thalassaemia trait | Haemoglobin studies; partner testing if planning pregnancy |
| Macrocytic | B12 or folate deficiency, alcohol, liver disease, drugs | B12 and folate levels, liver and thyroid tests, film |
| Anaemia, high reticulocytes, low haptoglobin | Haemolysis | Direct antiglobulin test and blood film |
| Isolated low platelets, normal film | Immune thrombocytopenia, drugs, viral illness | Review medicines; urgent referral if bleeding or very low |
| Low platelets 5 to 10 days after heparin | Heparin-induced thrombocytopenia | Stop heparin, start a non-heparin anticoagulant |
| Prolonged INR and APTT, low fibrinogen | Disseminated intravascular coagulation | Treat the cause, haematology input, blood product support |
| High transferrin saturation and ferritin | Hereditary haemochromatosis | HFE genotype; venesection if confirmed |
Worked examples in AMC style
Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for haematology & oncology.
Example 1
A 62-year-old man sees his GP with tiredness for three months. He has no gut symptoms and eats a normal diet. Haemoglobin is 104 g/L, MCV 72 fL and ferritin 6 microgram/L. Coeliac serology is negative. His last bowel screening kit, two years ago, was negative.
What is the most appropriate next step?
-
Iron replacement is reasonable, but treating without finding the cause could miss a bowel or gastric cancer.
-
He now has iron deficiency, which is a diagnostic problem. Screening tests are for people without symptoms or signs.
-
A ferritin of 6 confirms iron deficiency. Electrophoresis is for suspected thalassaemia with normal iron stores.
-
Correct. Unexplained iron deficiency in a man needs both upper and lower endoscopy to look for a source of blood loss, including cancer.
-
CT may miss mucosal lesions and does not allow biopsy. Endoscopy is the first-line test.
Show answer and reasoning
Answer: D. Refer for gastroscopy and colonoscopy
- A. Iron replacement is reasonable, but treating without finding the cause could miss a bowel or gastric cancer.
- B. He now has iron deficiency, which is a diagnostic problem. Screening tests are for people without symptoms or signs.
- C. A ferritin of 6 confirms iron deficiency. Electrophoresis is for suspected thalassaemia with normal iron stores.
- D. Correct. Unexplained iron deficiency in a man needs both upper and lower endoscopy to look for a source of blood loss, including cancer.
- E. CT may miss mucosal lesions and does not allow biopsy. Endoscopy is the first-line test.
Iron deficiency in a man or postmenopausal woman needs a gut source excluded with endoscopy.
Based on: Gastroenterological Society of Australia guidance on iron deficiency
Example 2
A 54-year-old woman receiving chemotherapy for breast cancer presents to a rural hospital with fever of 38.6 degrees and rigors. Her last cycle was nine days ago. Pulse is 112 per minute and blood pressure 104/66 mmHg. The full blood count result will take about two hours.
What is the most appropriate next step?
-
Delay increases death in neutropenic sepsis. Treatment should not wait for the count.
-
Oral narrow-spectrum antibiotics are not adequate for suspected neutropenic sepsis in an unwell patient.
-
Correct. Fever after recent chemotherapy is neutropenic sepsis until proven otherwise. Take cultures and give empirical broad-spectrum IV antibiotics within one hour, then arrange transfer if needed.
-
Transfer may be needed, but antibiotics must be given first; the journey would delay them.
-
Treating the fever masks the problem and delays the antibiotics she needs.
Show answer and reasoning
Answer: C. Take blood cultures and give IV antibiotics
- A. Delay increases death in neutropenic sepsis. Treatment should not wait for the count.
- B. Oral narrow-spectrum antibiotics are not adequate for suspected neutropenic sepsis in an unwell patient.
- C. Correct. Fever after recent chemotherapy is neutropenic sepsis until proven otherwise. Take cultures and give empirical broad-spectrum IV antibiotics within one hour, then arrange transfer if needed.
- D. Transfer may be needed, but antibiotics must be given first; the journey would delay them.
- E. Treating the fever masks the problem and delays the antibiotics she needs.
Fever after chemotherapy means IV antibiotics within 60 minutes; do not wait for the count.
Based on: eviQ and Therapeutic Guidelines: Antibiotic (febrile neutropenia)
Example 3
A 49-year-old woman attends for a health check. She has no symptoms and no family history of bowel cancer. She returned her first National Bowel Cancer Screening Program kit last month and the result was positive. Examination is normal and her haemoglobin is 132 g/L.
What is the most appropriate next step?
-
Correct. A positive iFOBT in the national program needs a diagnostic colonoscopy, ideally soon after the result.
-
A negative repeat test does not cancel a positive one, because bleeding from polyps and cancers can be intermittent.
-
CT colonography is used when colonoscopy is not possible. It cannot remove polyps or take biopsies.
-
A normal haemoglobin does not exclude a polyp or early cancer. Reassurance is unsafe.
-
CEA is not a screening or diagnostic test for bowel cancer and a normal level means little.
Show answer and reasoning
Answer: A. Refer her for a colonoscopy
- A. Correct. A positive iFOBT in the national program needs a diagnostic colonoscopy, ideally soon after the result.
- B. A negative repeat test does not cancel a positive one, because bleeding from polyps and cancers can be intermittent.
- C. CT colonography is used when colonoscopy is not possible. It cannot remove polyps or take biopsies.
- D. A normal haemoglobin does not exclude a polyp or early cancer. Reassurance is unsafe.
- E. CEA is not a screening or diagnostic test for bowel cancer and a normal level means little.
A positive bowel screening test leads to colonoscopy, never to a repeat stool test.
Based on: National Bowel Cancer Screening Program (Department of Health, Disability and Ageing)
Quick recall
Tap a card to turn it over. If you can answer all eight without looking, move on to timed questions.
Where candidates lose marks
- Screening someone with symptoms
Rectal bleeding or iron deficiency means diagnostic tests, not a screening kit.
- Tumour markers as screening
CEA, CA-125 and similar markers are not population screening tests and should not be used alone to diagnose.
- Waiting for the neutrophil count
Fever after chemotherapy is treated before the count returns.
- Folate before B12
Giving folate alone in combined deficiency can worsen neurological damage.
- UK screening ages
Australian bowel screening starts at 45 and cervical screening uses five-yearly HPV tests from 25.
How to study haematology & oncology
Day 1: Anaemia by MCV. Iron deficiency workup, thalassaemia trait, B12 and folate, haemolysis tests.
Day 2: Platelets and coagulation. ITP, HIT, coagulation patterns, von Willebrand disease and DIC.
Day 3: VTE and anticoagulation. Wells and D-dimer logic, DOAC versus warfarin choices, warfarin reversal.
Day 4: Haematological cancers. Leukaemias, lymphoma, myeloma and myeloproliferative disorders.
Day 5: Oncological emergencies and palliative care. Neutropenic sepsis, cord compression, hypercalcaemia, tumour lysis, symptom control.
Day 6: Australian screening programs. Learn ages and intervals, then do a mixed timed set of 40 questions.
Sources and further reading
Check the current edition of each guideline before your exam. This page is study material, not clinical advice.